Citius Pharmaceuticals, Inc. (CTXR) Free cash flow 2018–2022
Citius Pharmaceuticals, Inc. (CTXR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.4MFY2022 · since FY2018: -$11.3M → -$28.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$28.4M | -17.0% |
| FY2021 | -$24.3M | — |
| FY2018 | -$11.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice